PNC Financial Services Group’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $877K | Buy |
2,774
+432
| +18% | +$102K | ﹤0.01% | 1459 |
|
|
2026
Q1 | $468K | Buy |
2,342
+102
| +5% | +$20.2K | ﹤0.01% | 1727 |
|
|
2025
Q4 | $424K | Buy |
2,240
+410
| +22% | +$78.8K | ﹤0.01% | 1782 |
|
|
2025
Q3 | $324K | Buy |
1,830
+174
| +11% | +$25.9K | ﹤0.01% | 1950 |
|
|
2025
Q2 | $188K | Sell |
1,656
-374
| -18% | -$40K | ﹤0.01% | 2252 |
|
|
2025
Q1 | $213K | Sell |
2,030
-71
| -3% | -$8.03K | ﹤0.01% | 2138 |
|
|
2024
Q4 | $225K | Buy |
2,101
+69
| +3% | +$7.8K | ﹤0.01% | 2113 |
|
|
2024
Q3 | $203K | Sell |
2,032
-14
| -0.7% | -$1.41K | ﹤0.01% | 2160 |
|
|
2024
Q2 | $172K | Sell |
2,046
-165
| -7% | -$13.1K | ﹤0.01% | 2260 |
|
|
2024
Q1 | $162K | Buy |
2,211
+371
| +20% | +$27.4K | ﹤0.01% | 2326 |
|
|
2023
Q4 | $131K | Buy |
1,840
+450
| +32% | +$26.6K | ﹤0.01% | 2431 |
|
|
2023
Q3 | $83.3K | Sell |
1,390
-155
| -10% | -$10.2K | ﹤0.01% | 2680 |
|
|
2023
Q2 | $111K | Sell |
1,545
-20
| -1% | -$1.5K | ﹤0.01% | 2584 |
|
|
2023
Q1 | $115K | Buy |
1,565
+130
| +9% | +$9.24K | ﹤0.01% | 2479 |
|
|
2022
Q4 | $95.9K | Sell |
1,435
-601
| -30% | -$39.1K | ﹤0.01% | 2583 |
|
|
2022
Q3 | $110K | Buy |
2,036
+633
| +45% | +$37.2K | ﹤0.01% | 2472 |
|
|
2022
Q2 | $78K | Sell |
1,403
-533
| -28% | -$30.2K | ﹤0.01% | 2736 |
|
|
2022
Q1 | $135K | Buy |
1,936
+118
| +6% | +$8.56K | ﹤0.01% | 2518 |
|
|
2021
Q4 | $175K | Buy |
1,818
+201
| +12% | +$18.6K | ﹤0.01% | 2329 |
|
|
2021
Q3 | $141K | Buy |
1,617
+599
| +59% | +$46.3K | ﹤0.01% | 2409 |
|
|
2021
Q2 | $84K | Sell |
1,018
-38
| -4% | -$3.16K | ﹤0.01% | 2757 |
|
|
2021
Q1 | $101K | Buy |
1,056
+107
| +11% | +$10.1K | ﹤0.01% | 2573 |
|
|
2020
Q4 | $60K | Sell |
949
-394
| -29% | -$22.5K | ﹤0.01% | 2786 |
|
|
2020
Q3 | $80K | Sell |
1,343
-161
| -11% | -$11K | ﹤0.01% | 2444 |
|
|
2020
Q2 | $105K | Sell |
1,504
-234
| -13% | -$14.8K | ﹤0.01% | 2296 |
|
|
2020
Q1 | $79K | Sell |
1,738
-263
| -13% | -$14.9K | ﹤0.01% | 2354 |
|
|
2019
Q4 | $129K | Buy |
2,001
+255
| +15% | +$17K | ﹤0.01% | 2342 |
|
|
2019
Q3 | $108K | Sell |
1,746
-1,832
| -51% | -$115K | ﹤0.01% | 2491 |
|
|
2019
Q2 | $254K | Buy |
3,578
+420
| +13% | +$30.9K | ﹤0.01% | 2029 |
|
|
2019
Q1 | $249K | Buy |
3,158
+50
| +2% | +$3.79K | ﹤0.01% | 2015 |
|
|
2018
Q4 | $263K | Sell |
3,108
-44,083
| -93% | -$4.7M | ﹤0.01% | 1896 |
|
|
2018
Q3 | $8.08M | Sell |
47,191
-16,261
| -26% | -$2.45M | 0.01% | 604 |
|
|
2018
Q2 | $8.2M | Buy |
63,452
+95
| +0.1% | +$10.6K | 0.01% | 596 |
|
|
2018
Q1 | $6.53M | Sell |
63,357
-290
| -0.5% | -$28.7K | 0.01% | 639 |
|
|
2017
Q4 | $5.44M | Buy |
63,647
+19,941
| +46% | +$1.73M | 0.01% | 702 |
|
|
2017
Q3 | $3.71M | Buy |
43,706
+27,716
| +173% | +$2.19M | ﹤0.01% | 813 |
|
|
2017
Q2 | $1.21M | Buy |
15,990
+774
| +5% | +$54.1K | ﹤0.01% | 1183 |
|
|
2017
Q1 | $1M | Sell |
15,216
-6,918
| -31% | -$455K | ﹤0.01% | 1290 |
|
|
2016
Q4 | $1.4M | Sell |
22,134
-7,170
| -24% | -$452K | ﹤0.01% | 1140 |
|
|
2016
Q3 | $1.87M | Sell |
29,304
-662
| -2% | -$48.6K | ﹤0.01% | 1015 |
|
|
2016
Q2 | $2.23M | Buy |
29,966
+442
| +1% | +$32.8K | ﹤0.01% | 896 |
|
|
2016
Q1 | $1.97M | Buy |
29,524
+9,281
| +46% | +$564K | ﹤0.01% | 943 |
|
|
2015
Q4 | $1.37M | Buy |
20,243
+239
| +1% | +$14.8K | ﹤0.01% | 1070 |
|
|
2015
Q3 | $1.07M | Buy |
20,004
+388
| +2% | +$23.5K | ﹤0.01% | 1201 |
|
|
2015
Q2 | $1.23M | Buy |
19,616
+4,117
| +27% | +$225K | ﹤0.01% | 1190 |
|
|
2015
Q1 | $745K | Buy |
15,499
+3,680
| +31% | +$141K | ﹤0.01% | 1385 |
|
|
2014
Q4 | $392K | Sell |
11,819
-5,740
| -33% | -$187K | ﹤0.01% | 1673 |
|
|
2014
Q3 | $515K | Sell |
17,559
-4,625
| -21% | -$154K | ﹤0.01% | 1462 |
|
|
2014
Q2 | $862K | Sell |
22,184
-1,669
| -7% | -$67.7K | ﹤0.01% | 1146 |
|
|
2014
Q1 | $1M | Buy |
23,853
+2,605
| +12% | +$109K | ﹤0.01% | 1073 |
|
|
2013
Q4 | $697K | Sell |
21,248
-11,184
| -34% | -$364K | ﹤0.01% | 1190 |
|
|
2013
Q3 | $876K | Sell |
32,432
-5,110
| -14% | -$144K | ﹤0.01% | 1062 |
|
|
2013
Q2 | $876K | Buy |
+37,542
| New | +$675K | ﹤0.01% | 1030 |
|
Other funds holding LGND
JT
CAM
PNC Financial Services Group's LGND Position: Q2 2026 in Review
PNC Financial Services Group increased its Ligand Pharmaceuticals (LGND) stake by 18% in Q2 2026, buying an estimated $102K and bringing the position to 2,774 shares worth $877K. The position accounts for ﹤0.01% of the portfolio, ranked #1459.
PNC Financial Services Group first reported a position in LGND in Q2 2013 and has held it in 53 quarters since. The position peaked at $8.2M in Q2 2018. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.
- PNC Financial Services Group held 2,774 shares of Ligand Pharmaceuticals worth $877K as of Q2 2026.
- PNC Financial Services Group bought 432 Ligand Pharmaceuticals shares in Q2 2026, an estimated $102K.
- Ligand Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #1459 holding.
- PNC Financial Services Group first reported a position in Ligand Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- PNC Financial Services Group's Ligand Pharmaceuticals position peaked at $8.2M in Q2 2018.
- 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.
Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.